This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis
npj Systems Biology and Applications Open Access 12 December 2023
-
FinnGen provides genetic insights from a well-phenotyped isolated population
Nature Open Access 18 January 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
FDA approves anti-LAG3 checkpoint. Nat Biotechnol 40, 625 (2022). https://doi.org/10.1038/s41587-022-01331-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01331-0
This article is cited by
-
Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis
npj Systems Biology and Applications (2023)
-
Dynamics and specificities of T cells in cancer immunotherapy
Nature Reviews Cancer (2023)
-
FinnGen provides genetic insights from a well-phenotyped isolated population
Nature (2023)